119th Congress · introduced in the Senate · Jul 15, 2026
ONSHORE Manufacturing Act
Official title from Congress.gov
Latest action (Jul 15, 2026): Read twice and referred to the Committee on Finance.
View on Congress.govPolicy area: Taxation
No official summary has been published for this bill.
No cosponsors.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
6 citations.
BAXTER HEALTHCARE CORPORATION · lobbying firm or registrant: THE NICKLES GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Trade (domestic/foreign)
$50,000
Paid to lobbying firm
Issues related to tariffs. S. 4994, the ONSHORE Manufacturing Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PREMIER, INC. · lobbying firm or registrant: PREMIER, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$260,000
Spent on own lobbying
S. 4994, ONSHORE Manufacturing Act S. 998, H.R. 2213 Medical Supply Chain Resiliency Act S. 1058, H.R. 2172 Preserving Patients Access to Home Infusion Act H.R. 4559 P…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ROCHESTER REGIONAL HEALTH · lobbying firm or registrant: ROCHESTER REGIONAL HEALTH
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Budget/Appropriations
$30,000
Spent on own lobbying
…pt Hospital Transparency Act. -H.R. 9599, SECURE 340B Act. -H.R. 7961, H-1Bs for Physicians and the Healthcare Workforce Act. -H.R. 5269/S. 2761, RESULTS ACT. -S.4994, ONSHORE Manufacturing Act. -340B policy issues. -Site Neutral Payment Proposals. -Healthcare and hospital workforce budget and appropriations, generally. -Med…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ROCHESTER REGIONAL HEALTH · lobbying firm or registrant: ROCHESTER REGIONAL HEALTH
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Health Issues
$30,000
Spent on own lobbying
…pt Hospital Transparency Act. -H.R. 9599, SECURE 340B Act. -H.R. 7961, H-1Bs for Physicians and the Healthcare Workforce Act. -H.R. 5269/S. 2761, RESULTS ACT. -S.4994, ONSHORE Manufacturing Act. -340B policy issues. -Site Neutral Payment Proposals. -Healthcare and hospital workforce budget and appropriations, generally. -Med…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CHEVRON, USA, INC. · lobbying firm or registrant: ENS RESOURCES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 11, 2026 · issue area: Transportation
$20,000
Paid to lobbying firm
Monitor and support development of WRDA 2026 (S. 4994/H.R. 9497) related to beneficial use of dredge material policy.
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CHEVRON, USA, INC. · lobbying firm or registrant: ENS RESOURCES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Transportation
$10,000
Paid to lobbying firm
Monitor developement of WRDA 2026 (S. 4994/H.R. 9497) related to beneficial use of dredge material.
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing